Log In Get Started
Press Releases April 1, 2026 08:00 PM

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

RxSight to Participate in the 25th Annual Needham Virtual Healthcare Conference with Management Fireside Chat Scheduled

By Jordan Park RXST
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
RXST

RxSight, Inc., a company specializing in ophthalmic medical devices, announced its participation in the 25th Annual Needham Virtual Healthcare Conference, featuring a management fireside chat on April 16, 2026. The company highlights its innovative Light Adjustable Lens system that allows post-surgery vision customization for cataract patients.

Key Points

  • RxSight will present at the Needham Virtual Healthcare Conference on April 16, 2026.
  • The company’s Light Adjustable Lens system is the first adjustable intraocular lens technology available commercially.
  • The participation will include a live and archived webcast accessible via the company’s investor relations website.
  • The ophthalmic medical devices sector and healthcare technology markets may be influenced by RxSight’s innovation exposure.

ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company’s investor relations website at https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
[email protected]


Risks

  • Market adoption of the Light Adjustable Lens system may be slower than expected, limiting revenue growth.
  • Competition in the ophthalmic medical device industry could impact RxSight’s market share and profitability.
  • Regulatory changes or challenges could affect the approval and commercialization of their intraocular lens technology.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026